GPV is a marker of in vivo platelet activation - Study in a rat thrombosis model

Thrombosis and Haemostasis

Volumn 83, Issue 2, 2000, Pages 327-333

  Ravanat, Catherine ^b   Freund, Monique ^b   Mangin, Pierre ^b   Azorsa, David O ^b   Schwartz, Catherine ^a   Moog, Sylvie ^b   Schuhler, Simone ^b   Dambach, Josiane ^b   Cazenave, Jean Pierre ^b   Lanza, François ^b  

^a INSERM   (France)

^b NONE

Author keywords

Animal model; Flow cytometry; Prethrombotic state; Rat GPV; Thrombin generation

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; GLYCOPROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN V; GUANINE NUCLEOTIDE BINDING PROTEIN; HIRUDIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECEPTOR; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HALF LIFE TIME; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOSIS;

EID: 0038473318     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613807     Document Type: Article

References (39)

1. Ware J. Molecular analyses of the platelet glycoprotein Ib-IX-V. Thromb Haemost 1998; 79: 466-78.
2. Jamieson GA. Pathophysiology of platelet thrombin receptors. Thromb Haemost 1997; 78: 242-6.
3. Mazzucato M, De Marco L, Masotti A, Pradella P, Bahou WF, Ruggeri ZM. Characterization of the initial α-thrombin interaction with glycoprotein Ibα in relation to platelet activation. J Biol Chem 1998; 23: 1880-7.
4. 2+] induced by α-thrombin. Biochemistry 1996; 35: 906-14.
5. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
6. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6.
7. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tram C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
8. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-887.
9. Connolly TM, Condra C, Feng DM, Cook JJ, Stranieri MT, Reilly CF, Nutt RF, Gould RJ. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb Haemost 1994; 72: 627-33.
10. Kinlough-Rathbone RL, Rand ML, Packham MA. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood 1993; 82: 103-6.
11. Cook NS, Zerwes HG, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A. Platelet aggregation and fibrinogen binding in human, Rhesus monkey, guinea pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemost 1993; 70: 531-9.
12. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381: 516-9.
13. Berndt MC, Phillips DR. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem 1981; 256: 59-65.
14. Bienz D, Shnippering W, Clemetson KJ. Glycoprotein V is not the thrombin activation receptor on human platelets. Blood 1986; 68: 720-5.
15. Dong JF, Sac-Tung G, Lopez JA. Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site. Blood 1997; 89: 4355-63.
16. Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AEG. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-69.
17. Takafuta T, Fujimura K, Kawano H, Noda M, Fujimoto T, Oda K, Shimomura T, Kuramoto A. Expression of platelet membrane glycoprotein V in human megakaryocytes and megakaryocytic cell lines: a study using a novel monoclonal antibody against GPV. Thromb Haemost 1994; 72: 762-9.
18. Lanza F, Morales M, de La Salle C, Cazenave JP, Clemetson KJ, Shimomura T, Phillips DR. Cloning and characterization of the gene encoding the human platelet GPV. J Biol Chem 1993; 270: 20801-7.
19. Ravanat C, Morales M, Azorsa DO, Moog S, Schuhler S, Grunert P, Loew D. Van Dorsselaer A, Cazenave JP, Lanza F. Gene cloning of rat and mouse platelet Glycoprotein V: identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 1997; 89: 3253-62.
20. Azorsa DO, Moog S, Ravanat C, Schuhler S, Folléa G, Cazenave J.P. Lanza F. Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA - Its use to follow platelet storage in transfusion. Thromb Haemost 1999; 81: 131-8.
21. Katsutani S, Fujimoto TT, Noda M, Shimomura T, Takafuta T, Kimura A, Fujimura K. Cloning and characterization of the gene encoding the murine glycoprotein V: The conserved thrombin-cleaved protein on platelet surface. Thromb Res 1998; 92: 43-51.
22. McGowan EB, Ding A, Detwiler TC. Correlation of thrombin-induced Glycoprotein V hydrolysis and platelet activation. J Biol Chem 1983; 258: 11243-8.
23. Wicki AN, Clemetson KJ. Structure and function of platelet membrane GPIb and V. Effects of leukocyte elastase and other proteases on platelet response to von Willebrand factor and thrombin. Eur J Biochem 1985; 153: 1-11.
24. Michelson AD, Benoit SE, Furman MI, Barnard MR, Nurden P, Nurden AT. The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: Proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system. Blood 1996; 87: 1396-408.
25. Ravanat C, Freund M, Schuhler S, Grunert P, Meyer L, Cazenave JP. Species specific immunoassays to measure blood platelet and coagulation activation in the rat. Thromb Haemost 1996; 76: 1090-5.
26. McKinney MM, Parkinson A. A simple, non-chromalographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Meth 1987; 96: 271-8.
27. Ravanat C, Freund M, Dol F, Cadroy Y, Roussi J, Incardona F, Maffrand JP, Boneu B, Drouet L, Legrand C, Herbert JM, Cazenave JP. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coag Fibrinol 1995; 6: 446-55.
28. Cazenave JP, Hemmendinger S., Beretz A, Suiter-Bay A, Launay J. L'agrégation plaquettaire: outil d'investigation clinique et d'étude pharmacologique. Méthodologie. Ann Biol Clin 1983; 41: 167-79.
29. Michelson AD. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coag Fibrinol 1994; 5: 121-31.
30. Fredrich M, Zierz R, Morser J, Wydro R, Witt W. A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream. Blood Coag Fibrinol 1994; 5: 243-8.
31. Harvey RP, Degryse E. Stefani L, Schamber F, Cazenave JP, Courtney M, Tolstoshev P, Lecoq JP. Cloning and expression of a cDNA coding for the anticoagulant hirudin from bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci USA 1986; 83: 1084-8.
32. Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, Hiyoyama K, Nisikawa M, Gabazza EC, Deguchi K, Kazama M, Shiku H. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol 1999; 60: 273-8.
33. Bick RL. Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations. Semin Thromb Hemost 1998; 24: 3-18.
34. Cox D. Methods for monitoring platelet function. Am Heart J 1998; 135: S160-9.
35. Zucker MB, Katz IR. Platelet factor 4: production, structure and physiologic and immunologic action. Proc Soc Exp Biol Med 1991; 198: 693-702.
36. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA. 1996; 93: 11877-82.
37. Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood 1998; 92: 4446-52.
38. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet α-granule release in vivo. Blood 1981; 58: 607-18.
39. Ikeda H, Nakayama H, Oda T, Kuwano K, Muraishi A, Sugi K, Koga Y, Toshima H. Soluble form of P-selectin in patients with acute myocardial infarction. Coron Artery Dis 1994; 5: 515-8.